/
News

Aetion Announces Partnership with the U.S. Food & Drug Administration and Brigham and Women’s Hospital/Harvard Medical School to Integrate Real-World Evidence into Regulatory Decision-Making

Date May 9, 2018
Category News
Related Company Aetion
Flare Capital Partners

We invest in exceptional founders transforming healthcare.

Our entrepreneurs are addressing important issues across the entire healthcare technology industry.

Share insight